We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
11 hedge funds and large institutions have $247K invested in Plus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
110% more capital invested
Capital invested by funds: $118K → $247K (+$130K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
10% more funds holding
Funds holding: 10 → 11 (+1)
0% more ownership
Funds ownership: 0.12% → 0.12% (+0%)
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$52.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$27K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.2K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$22.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.01K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$26.5K |
| 2 |
HF
HRT Financial
New York
|
-$15K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.4K |
| 4 |
Citigroup
New York
|
-$776 |